ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat

ClinicalTrials.gov ID: NCT01510769

Public ClinicalTrials.gov record NCT01510769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Febuxostat Compared to Febuxostat Alone at Lowering Serum Uric Acid and Resolving Tophi in Subjects With Tophaceous Gout

Study identification

NCT ID
NCT01510769
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ardea Biosciences, Inc.
Industry
Enrollment
330 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2011
Primary completion
May 31, 2014
Completion
May 31, 2014
Last update posted
May 25, 2016

2012 – 2014

United States locations

U.S. sites
49
U.S. states
15
U.S. cities
41
Facility City State ZIP Site status
Not listed Birmingham Alabama 35211
Not listed Goodyear Arizona 85395
Not listed Peoria Arizona 85381
Not listed Pheonix Arizona 85023
Not listed Tucson Arizona 85724
Not listed Little Rock Arkansas 72204
Not listed Little Rock Arkansas 72223
Not listed Glendale California 91204
Not listed Huntington Beach California 92646
Not listed Irvine California 92618
Not listed La Jolla California 92037
Not listed Los Angeles California 90048
Not listed Rancho Cucamonga California 91730
Not listed San Diego California 92108
Not listed Denver Colorado 80220
Not listed Denver Colorado 80230
Not listed Englewood Colorado 80113
Not listed Trumball Connecticut 06611
Not listed Washington D.C. District of Columbia 20422
Not listed Boynton Beach Florida 33472
Not listed Brooksville Florida 34601
Not listed East Brandenton Florida 34208
Not listed Fleming Island Florida 32003
Not listed Miami Florida 33135
Not listed Napels Florida 34102
Not listed Pembroke Pines Florida 33027
Not listed Pembroke Pines Florida 33029
Not listed Port Orange Florida 32127
Not listed Tampa Florida 33606
Not listed Tampa Florida 33607
Not listed Tampa Florida 33614
Not listed Vero Beach Florida 32960
Not listed Winter Haven Florida 33880
Not listed Conyers Georgia 30013
Not listed Johns Creek Georgia 30097
Not listed Newnan Georgia 30265
Not listed Savannah Georgia 31406
Not listed Honolulu Hawaii 96814
Not listed Meridian Idaho 83642
Not listed Meridian Idaho 83646
Not listed Chicago Illinois 60624
Not listed Chicago Illinois 60637
Not listed Gurnee Illinois 60031
Not listed Springfield Illinois 62704
Not listed Springfield Illinois 62711
Not listed Elizabethtown Kentucky 42701
Not listed Lexington Kentucky 40504
Not listed Frederick Maryland 21702
Not listed Kalamazoo Michigan 49009

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01510769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 25, 2016 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01510769 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →